Award
Delivery Order #SPE2DP26F3200
Clindamycin Hydrochloride Delivery Order Awarded to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$86.01
Ceiling
$86.01
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 02, 2026
Identifier
SPE2DP26F3200
NAICS
424210
This award is a delivery order contract under an existing indefinite delivery vehicle, representing a focused pharmaceutical procurement effort. The recipient, DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceutical products, will supply Clindamycin Hydrochloride, an important antibiotic medication. The contract ensures timely and reliable access to this essential drug, supporting federal health agencies' treatment protocols and broader public health goals. The scope of work covers the provision and delivery of this specific pharmaceutical product to a designated location in Park Ridge, Illinois, on the contract's effective date. This delivery order builds on a larger definitive pharmaceutical supply contract held by DMS Pharmaceutical Group, which includes a wide range of medical drugs to support diverse healthcare needs. The contract was awarded through the established indefinite delivery vehicle, suggesting a competitive and strategic procurement process. The specified performance is a short-term, single-day delivery, fitting within the ongoing overarching supply agreement.
Description
8511951849!CLINDAMYCIN HYDROCH